Gene Symbol | Gene ID | Gene Info |
---|---|---|
KLF12
|
ENSG00000118922.12 | Kruppel like factor 12 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr13_74706686_74707383 | KLF12 | 1360 | 0.610790 | -0.84 | 4.8e-03 | Click! |
chr13_74707575_74707914 | KLF12 | 650 | 0.836514 | -0.79 | 1.2e-02 | Click! |
chr13_74636992_74637192 | KLF12 | 67906 | 0.143868 | -0.77 | 1.5e-02 | Click! |
chr13_74709839_74710349 | KLF12 | 1700 | 0.539429 | -0.72 | 2.8e-02 | Click! |
chr13_74710350_74710633 | KLF12 | 2097 | 0.481476 | -0.68 | 4.4e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_197831468_197832400 | 1.52 |
AC073135.3 |
|
5143 |
0.19 |
chr3_197825673_197826397 | 1.51 |
AC073135.3 |
|
11042 |
0.16 |
chr10_126916927_126917078 | 0.68 |
CTBP2 |
C-terminal binding protein 2 |
67372 |
0.13 |
chr6_166795582_166796398 | 0.63 |
MPC1 |
mitochondrial pyruvate carrier 1 |
496 |
0.56 |
chrX_48797424_48797575 | 0.62 |
OTUD5 |
OTU domain containing 5 |
16952 |
0.08 |
chrX_70330517_70330974 | 0.62 |
IL2RG |
interleukin 2 receptor, gamma |
553 |
0.61 |
chr6_154677089_154677240 | 0.61 |
IPCEF1 |
interaction protein for cytohesin exchange factors 1 |
705 |
0.8 |
chr3_197828693_197828955 | 0.61 |
AC073135.3 |
|
8253 |
0.17 |
chr11_47399612_47399968 | 0.60 |
SPI1 |
spleen focus forming virus (SFFV) proviral integration oncogene |
152 |
0.91 |
chr11_63273553_63274069 | 0.59 |
LGALS12 |
lectin, galactoside-binding, soluble, 12 |
24 |
0.97 |
chr3_197831153_197831453 | 0.56 |
AC073135.3 |
|
5774 |
0.19 |
chr17_76912776_76912997 | 0.51 |
TIMP2 |
TIMP metallopeptidase inhibitor 2 |
5597 |
0.15 |
chr3_197829934_197830170 | 0.51 |
AC073135.3 |
|
7025 |
0.18 |
chr5_177870010_177870161 | 0.49 |
CTB-26E19.1 |
|
10 |
0.98 |
chr5_178094483_178094634 | 0.46 |
CLK4 |
CDC-like kinase 4 |
40443 |
0.14 |
chr21_46955435_46955710 | 0.45 |
SLC19A1 |
solute carrier family 19 (folate transporter), member 1 |
1043 |
0.57 |
chr3_194456850_194457149 | 0.44 |
FAM43A |
family with sequence similarity 43, member A |
50377 |
0.11 |
chr9_132097203_132097398 | 0.43 |
ENSG00000242281 |
. |
35440 |
0.16 |
chr3_197827066_197827292 | 0.42 |
AC073135.3 |
|
9898 |
0.17 |
chr20_60760834_60760985 | 0.41 |
MTG2 |
mitochondrial ribosome-associated GTPase 2 |
2802 |
0.2 |
chr10_50396086_50396421 | 0.41 |
C10orf128 |
chromosome 10 open reading frame 128 |
104 |
0.97 |
chrX_71342618_71342899 | 0.40 |
RGAG4 |
retrotransposon gag domain containing 4 |
8920 |
0.16 |
chr21_40181513_40181664 | 0.39 |
ETS2 |
v-ets avian erythroblastosis virus E26 oncogene homolog 2 |
28 |
0.99 |
chr17_75142210_75142404 | 0.38 |
SEC14L1 |
SEC14-like 1 (S. cerevisiae) |
1579 |
0.4 |
chr12_54693178_54693413 | 0.38 |
NFE2 |
nuclear factor, erythroid 2 |
1504 |
0.18 |
chr17_75462246_75462493 | 0.38 |
SEPT9 |
septin 9 |
116 |
0.95 |
chr8_96064792_96064943 | 0.38 |
ENSG00000200525 |
. |
2575 |
0.23 |
chr3_197826796_197827012 | 0.38 |
AC073135.3 |
|
10173 |
0.17 |
chr12_54691575_54691887 | 0.37 |
NFE2 |
nuclear factor, erythroid 2 |
63 |
0.93 |
chr3_46968939_46969166 | 0.37 |
PTH1R |
parathyroid hormone 1 receptor |
24963 |
0.13 |
chr10_26911177_26911806 | 0.36 |
PDSS1 |
prenyl (decaprenyl) diphosphate synthase, subunit 1 |
75097 |
0.1 |
chr19_1155345_1155615 | 0.36 |
SBNO2 |
strawberry notch homolog 2 (Drosophila) |
345 |
0.81 |
chr3_197830597_197830892 | 0.36 |
AC073135.3 |
|
6333 |
0.18 |
chr17_80817564_80818630 | 0.36 |
TBCD |
tubulin folding cofactor D |
173 |
0.94 |
chr22_50550352_50550703 | 0.35 |
MOV10L1 |
Mov10l1, Moloney leukemia virus 10-like 1, homolog (mouse) |
21842 |
0.11 |
chr16_81832397_81832594 | 0.34 |
PLCG2 |
phospholipase C, gamma 2 (phosphatidylinositol-specific) |
19632 |
0.26 |
chr19_54784205_54784408 | 0.34 |
LILRB2 |
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 |
47 |
0.93 |
chrX_65238305_65238456 | 0.33 |
ENSG00000207939 |
. |
332 |
0.9 |
chr5_176936416_176936567 | 0.33 |
DOK3 |
docking protein 3 |
336 |
0.78 |
chr8_56792958_56793527 | 0.33 |
LYN |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
848 |
0.55 |
chr20_1471662_1471896 | 0.33 |
SIRPB2 |
signal-regulatory protein beta 2 |
263 |
0.87 |
chr16_89042423_89042673 | 0.33 |
CBFA2T3 |
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
853 |
0.55 |
chr1_33805040_33805319 | 0.32 |
ENSG00000222112 |
. |
2714 |
0.17 |
chr1_17635139_17635290 | 0.32 |
PADI4 |
peptidyl arginine deiminase, type IV |
522 |
0.76 |
chr7_73624740_73625015 | 0.32 |
LAT2 |
linker for activation of T cells family, member 2 |
524 |
0.74 |
chr6_6695474_6695863 | 0.32 |
LY86-AS1 |
LY86 antisense RNA 1 |
72664 |
0.12 |
chr21_39869780_39870199 | 0.32 |
ERG |
v-ets avian erythroblastosis virus E26 oncogene homolog |
356 |
0.93 |
chr19_50310817_50311209 | 0.32 |
FUZ |
fuzzy planar cell polarity protein |
883 |
0.28 |
chr11_10663106_10663406 | 0.32 |
MRVI1 |
murine retrovirus integration site 1 homolog |
10476 |
0.19 |
chr4_26076892_26077043 | 0.32 |
RBPJ |
recombination signal binding protein for immunoglobulin kappa J region |
88110 |
0.1 |
chr3_58339519_58339685 | 0.32 |
PXK |
PX domain containing serine/threonine kinase |
20569 |
0.17 |
chr1_245215310_245215673 | 0.32 |
ENSG00000251754 |
. |
8261 |
0.17 |
chr1_156125493_156125644 | 0.31 |
SEMA4A |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
1406 |
0.27 |
chr2_218990528_218990679 | 0.31 |
CXCR2 |
chemokine (C-X-C motif) receptor 2 |
124 |
0.96 |
chr14_105527834_105528220 | 0.31 |
GPR132 |
G protein-coupled receptor 132 |
3740 |
0.23 |
chr3_99792509_99792782 | 0.31 |
FILIP1L |
filamin A interacting protein 1-like |
40712 |
0.15 |
chr10_106081987_106082159 | 0.31 |
ITPRIP |
inositol 1,4,5-trisphosphate receptor interacting protein |
6609 |
0.14 |
chr16_89041933_89042084 | 0.31 |
CBFA2T3 |
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
1393 |
0.37 |
chr10_126917196_126917347 | 0.31 |
CTBP2 |
C-terminal binding protein 2 |
67641 |
0.13 |
chr6_35268574_35268725 | 0.31 |
DEF6 |
differentially expressed in FDCP 6 homolog (mouse) |
3020 |
0.24 |
chr10_75626324_75626588 | 0.31 |
CAMK2G |
calcium/calmodulin-dependent protein kinase II gamma |
5844 |
0.13 |
chr1_26868114_26868336 | 0.30 |
RPS6KA1 |
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
1378 |
0.34 |
chr11_72449633_72449911 | 0.30 |
ARAP1 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
11599 |
0.12 |
chr1_26870073_26870236 | 0.30 |
RPS6KA1 |
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
551 |
0.7 |
chr19_55105527_55105771 | 0.29 |
LILRA1 |
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 |
524 |
0.65 |
chr19_42302514_42302665 | 0.29 |
CEACAM3 |
carcinoembryonic antigen-related cell adhesion molecule 3 |
1504 |
0.28 |
chr12_133346878_133347204 | 0.29 |
ANKLE2 |
ankyrin repeat and LEM domain containing 2 |
8567 |
0.15 |
chr22_17598033_17598230 | 0.29 |
CECR6 |
cat eye syndrome chromosome region, candidate 6 |
4012 |
0.17 |
chr11_1328574_1328800 | 0.29 |
TOLLIP |
toll interacting protein |
2162 |
0.23 |
chr16_28506424_28506601 | 0.29 |
CLN3 |
ceroid-lipofuscinosis, neuronal 3 |
343 |
0.59 |
chr8_134086774_134086935 | 0.29 |
SLA |
Src-like-adaptor |
14251 |
0.23 |
chr6_2840053_2840204 | 0.29 |
SERPINB1 |
serpin peptidase inhibitor, clade B (ovalbumin), member 1 |
1966 |
0.32 |
chr3_5019013_5019527 | 0.29 |
BHLHE40 |
basic helix-loop-helix family, member e40 |
1531 |
0.38 |
chr11_68502790_68502941 | 0.29 |
MTL5 |
metallothionein-like 5, testis-specific (tesmin) |
16063 |
0.19 |
chr14_102677353_102677504 | 0.29 |
WDR20 |
WD repeat domain 20 |
16145 |
0.17 |
chr7_73624408_73624729 | 0.29 |
LAT2 |
linker for activation of T cells family, member 2 |
215 |
0.92 |
chr3_197827693_197827844 | 0.29 |
AC073135.3 |
|
9309 |
0.17 |
chr3_197830356_197830507 | 0.29 |
AC073135.3 |
|
6646 |
0.18 |
chr17_3820242_3820393 | 0.28 |
P2RX1 |
purinergic receptor P2X, ligand-gated ion channel, 1 |
523 |
0.75 |
chr1_28502388_28502717 | 0.28 |
PTAFR |
platelet-activating factor receptor |
1147 |
0.35 |
chr3_197829537_197829688 | 0.28 |
AC073135.3 |
|
7465 |
0.18 |
chr20_4794055_4794206 | 0.28 |
RASSF2 |
Ras association (RalGDS/AF-6) domain family member 2 |
1639 |
0.4 |
chr10_440689_440840 | 0.28 |
DIP2C |
DIP2 disco-interacting protein 2 homolog C (Drosophila) |
7015 |
0.21 |
chr2_185461919_185462338 | 0.28 |
ZNF804A |
zinc finger protein 804A |
965 |
0.73 |
chr3_197828427_197828578 | 0.28 |
AC073135.3 |
|
8575 |
0.17 |
chr11_65544144_65544295 | 0.28 |
AP5B1 |
adaptor-related protein complex 5, beta 1 subunit |
4054 |
0.11 |
chr18_44181171_44181332 | 0.28 |
LOXHD1 |
lipoxygenase homology domains 1 |
228 |
0.96 |
chr4_91048244_91048537 | 0.28 |
CCSER1 |
coiled-coil serine-rich protein 1 |
346 |
0.94 |
chr17_79133696_79133927 | 0.28 |
AATK-AS1 |
AATK antisense RNA 1 |
5496 |
0.1 |
chr11_8228040_8228278 | 0.28 |
RIC3 |
RIC3 acetylcholine receptor chaperone |
37557 |
0.16 |
chr11_47396157_47396308 | 0.27 |
SPI1 |
spleen focus forming virus (SFFV) proviral integration oncogene |
3710 |
0.12 |
chr1_27951514_27951705 | 0.27 |
FGR |
feline Gardner-Rasheed sarcoma viral oncogene homolog |
1036 |
0.44 |
chr1_161600101_161600252 | 0.27 |
FCGR3B |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) |
646 |
0.42 |
chr19_33783790_33784192 | 0.27 |
CTD-2540B15.11 |
|
6849 |
0.13 |
chr19_33791374_33791575 | 0.27 |
CTD-2540B15.11 |
|
634 |
0.4 |
chr17_47307213_47307364 | 0.27 |
PHOSPHO1 |
phosphatase, orphan 1 |
602 |
0.68 |
chr19_18507804_18508682 | 0.27 |
LRRC25 |
leucine rich repeat containing 25 |
178 |
0.89 |
chr10_94452035_94452186 | 0.27 |
HHEX |
hematopoietically expressed homeobox |
498 |
0.8 |
chr16_85793045_85793254 | 0.27 |
C16orf74 |
chromosome 16 open reading frame 74 |
8414 |
0.11 |
chr12_10280937_10281088 | 0.27 |
CLEC7A |
C-type lectin domain family 7, member A |
1669 |
0.27 |
chr7_101928648_101928947 | 0.27 |
SH2B2 |
SH2B adaptor protein 2 |
345 |
0.82 |
chr1_161185105_161185306 | 0.27 |
FCER1G |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
118 |
0.89 |
chr16_31138973_31139124 | 0.26 |
KAT8 |
K(lysine) acetyltransferase 8 |
455 |
0.56 |
chr20_5551143_5551294 | 0.26 |
GPCPD1 |
glycerophosphocholine phosphodiesterase GDE1 homolog (S. cerevisiae) |
4936 |
0.28 |
chr3_107851409_107852101 | 0.26 |
CD47 |
CD47 molecule |
41883 |
0.19 |
chr22_30659617_30659828 | 0.26 |
OSM |
oncostatin M |
2085 |
0.18 |
chr12_7067641_7067951 | 0.26 |
ENSG00000207713 |
. |
5066 |
0.06 |
chr11_67053296_67053447 | 0.26 |
ANKRD13D |
ankyrin repeat domain 13 family, member D |
2647 |
0.17 |
chr10_73510613_73510786 | 0.26 |
C10orf54 |
chromosome 10 open reading frame 54 |
6688 |
0.2 |
chr1_153363293_153363489 | 0.26 |
S100A8 |
S100 calcium binding protein A8 |
61 |
0.95 |
chr9_69785762_69786779 | 0.26 |
IGKV1OR-2 |
immunoglobulin kappa variable 1/OR-2 (pseudogene) |
8317 |
0.25 |
chr15_38334834_38334985 | 0.26 |
TMCO5A |
transmembrane and coiled-coil domains 5A |
107451 |
0.08 |
chr9_136208277_136208487 | 0.26 |
ENSG00000201451 |
. |
3721 |
0.08 |
chr9_37913420_37913571 | 0.26 |
SLC25A51 |
solute carrier family 25, member 51 |
9365 |
0.22 |
chr3_197829349_197829500 | 0.26 |
AC073135.3 |
|
7653 |
0.18 |
chr4_74809740_74810515 | 0.26 |
PF4 |
platelet factor 4 |
37714 |
0.11 |
chr1_161593652_161593803 | 0.26 |
FCGR3B |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) |
7095 |
0.12 |
chr7_5501942_5502166 | 0.25 |
ENSG00000238394 |
. |
22972 |
0.11 |
chr17_79133935_79134086 | 0.25 |
AATK-AS1 |
AATK antisense RNA 1 |
5297 |
0.1 |
chr20_55950478_55950629 | 0.25 |
MTRNR2L3 |
MT-RNR2-like 3 |
15675 |
0.12 |
chr16_89003788_89003939 | 0.25 |
RP11-830F9.7 |
|
301 |
0.83 |
chr6_611280_611431 | 0.25 |
HUS1B |
HUS1 checkpoint homolog b (S. pombe) |
45608 |
0.17 |
chr17_76776046_76776325 | 0.25 |
CYTH1 |
cytohesin 1 |
2169 |
0.3 |
chr20_62708665_62709256 | 0.25 |
RGS19 |
regulator of G-protein signaling 19 |
1885 |
0.17 |
chr2_169939774_169939925 | 0.25 |
DHRS9 |
dehydrogenase/reductase (SDR family) member 9 |
2232 |
0.33 |
chr12_49627195_49627425 | 0.25 |
TUBA1C |
tubulin, alpha 1c |
5601 |
0.13 |
chr5_176732926_176733077 | 0.25 |
PRELID1 |
PRELI domain containing 1 |
1312 |
0.28 |
chr11_10627173_10627324 | 0.25 |
MRVI1-AS1 |
MRVI1 antisense RNA 1 |
12504 |
0.17 |
chr3_46248645_46248796 | 0.25 |
CCR1 |
chemokine (C-C motif) receptor 1 |
1167 |
0.54 |
chr2_71681786_71681937 | 0.25 |
DYSF |
dysferlin |
1009 |
0.63 |
chrX_12926467_12926618 | 0.25 |
TLR8-AS1 |
TLR8 antisense RNA 1 |
90 |
0.96 |
chr19_18134589_18135083 | 0.25 |
ARRDC2 |
arrestin domain containing 2 |
15859 |
0.14 |
chr16_434070_434221 | 0.25 |
TMEM8A |
transmembrane protein 8A |
2163 |
0.17 |
chr21_39867699_39867850 | 0.25 |
ERG |
v-ets avian erythroblastosis virus E26 oncogene homolog |
2571 |
0.43 |
chr19_52252047_52252198 | 0.25 |
FPR1 |
formyl peptide receptor 1 |
1942 |
0.21 |
chr9_95727201_95727619 | 0.25 |
FGD3 |
FYVE, RhoGEF and PH domain containing 3 |
1167 |
0.54 |
chr11_58978296_58978447 | 0.25 |
MPEG1 |
macrophage expressed 1 |
2053 |
0.27 |
chr8_25059023_25059435 | 0.25 |
DOCK5 |
dedicator of cytokinesis 5 |
16849 |
0.22 |
chr14_70120562_70120713 | 0.25 |
KIAA0247 |
KIAA0247 |
42324 |
0.16 |
chr17_2699734_2700214 | 0.25 |
RAP1GAP2 |
RAP1 GTPase activating protein 2 |
198 |
0.94 |
chr7_128048882_128049033 | 0.25 |
IMPDH1 |
IMP (inosine 5'-monophosphate) dehydrogenase 1 |
998 |
0.47 |
chr20_3994903_3996170 | 0.25 |
RNF24 |
ring finger protein 24 |
500 |
0.83 |
chr1_17446030_17446253 | 0.25 |
PADI2 |
peptidyl arginine deiminase, type II |
193 |
0.94 |
chr19_45256119_45256273 | 0.25 |
BCL3 |
B-cell CLL/lymphoma 3 |
1618 |
0.24 |
chr4_38531163_38531332 | 0.25 |
RP11-617D20.1 |
|
94949 |
0.08 |
chr17_1548578_1548729 | 0.24 |
SCARF1 |
scavenger receptor class F, member 1 |
385 |
0.74 |
chr2_113932280_113932569 | 0.24 |
AC016683.5 |
|
490 |
0.59 |
chr1_65430726_65432146 | 0.24 |
JAK1 |
Janus kinase 1 |
751 |
0.73 |
chr14_20895899_20896050 | 0.24 |
KLHL33 |
kelch-like family member 33 |
7827 |
0.08 |
chr19_11432573_11432724 | 0.24 |
CTC-510F12.6 |
|
184 |
0.88 |
chr4_3039964_3040368 | 0.24 |
ENSG00000199335 |
. |
5662 |
0.19 |
chr2_233926827_233927087 | 0.24 |
INPP5D |
inositol polyphosphate-5-phosphatase, 145kDa |
1768 |
0.35 |
chr7_50345023_50345395 | 0.24 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
831 |
0.74 |
chr10_70849708_70849969 | 0.24 |
SRGN |
serglycin |
1964 |
0.33 |
chr6_41168637_41168931 | 0.24 |
TREML2 |
triggering receptor expressed on myeloid cells-like 2 |
148 |
0.93 |
chr15_91428234_91428460 | 0.24 |
FES |
feline sarcoma oncogene |
71 |
0.94 |
chr14_77873229_77873401 | 0.24 |
FKSG61 |
|
9426 |
0.11 |
chr7_37382144_37382404 | 0.24 |
ELMO1 |
engulfment and cell motility 1 |
93 |
0.97 |
chr2_43333372_43333523 | 0.24 |
ENSG00000207087 |
. |
14815 |
0.27 |
chr4_185781635_185781786 | 0.24 |
ENSG00000266698 |
. |
9446 |
0.2 |
chr15_31558914_31559065 | 0.24 |
KLF13 |
Kruppel-like factor 13 |
60069 |
0.14 |
chr22_24038076_24038227 | 0.24 |
RGL4 |
ral guanine nucleotide dissociation stimulator-like 4 |
520 |
0.69 |
chrX_30594869_30596024 | 0.24 |
CXorf21 |
chromosome X open reading frame 21 |
515 |
0.84 |
chr11_3855665_3855911 | 0.24 |
RHOG |
ras homolog family member G |
3309 |
0.13 |
chr12_94567701_94567872 | 0.24 |
RP11-74K11.2 |
|
2394 |
0.32 |
chr12_123373053_123373596 | 0.24 |
VPS37B |
vacuolar protein sorting 37 homolog B (S. cerevisiae) |
1382 |
0.39 |
chr20_4791271_4791422 | 0.24 |
RASSF2 |
Ras association (RalGDS/AF-6) domain family member 2 |
4423 |
0.23 |
chr8_56851767_56852412 | 0.24 |
LYN |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
704 |
0.63 |
chr1_150975096_150975673 | 0.24 |
FAM63A |
family with sequence similarity 63, member A |
3577 |
0.1 |
chr8_142288307_142288672 | 0.24 |
RP11-10J21.3 |
Uncharacterized protein |
23825 |
0.12 |
chr2_208015092_208015258 | 0.24 |
KLF7 |
Kruppel-like factor 7 (ubiquitous) |
15120 |
0.19 |
chr9_124115790_124115941 | 0.24 |
AL161784.1 |
Uncharacterized protein |
12240 |
0.14 |
chr16_29756930_29757303 | 0.24 |
C16orf54 |
chromosome 16 open reading frame 54 |
211 |
0.73 |
chr2_68962051_68962936 | 0.24 |
ARHGAP25 |
Rho GTPase activating protein 25 |
479 |
0.86 |
chr22_24536224_24536535 | 0.24 |
CABIN1 |
calcineurin binding protein 1 |
15427 |
0.16 |
chr20_55059093_55059344 | 0.24 |
ENSG00000238294 |
. |
8519 |
0.13 |
chr19_54823726_54823877 | 0.23 |
LILRA5 |
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 |
543 |
0.6 |
chr10_81054866_81055072 | 0.23 |
ZMIZ1 |
zinc finger, MIZ-type containing 1 |
11006 |
0.24 |
chr3_197829008_197829159 | 0.23 |
AC073135.3 |
|
7994 |
0.18 |
chr5_176937088_176937239 | 0.23 |
DOK3 |
docking protein 3 |
220 |
0.87 |
chr12_7060685_7060854 | 0.23 |
PTPN6 |
protein tyrosine phosphatase, non-receptor type 6 |
231 |
0.78 |
chr2_113931904_113932161 | 0.23 |
PSD4 |
pleckstrin and Sec7 domain containing 4 |
458 |
0.63 |
chr4_185748277_185748428 | 0.23 |
ACSL1 |
acyl-CoA synthetase long-chain family member 1 |
380 |
0.86 |
chr17_30646004_30646155 | 0.23 |
C17orf75 |
chromosome 17 open reading frame 75 |
15483 |
0.14 |
chr2_87874283_87874487 | 0.23 |
ENSG00000265507 |
. |
54889 |
0.15 |
chr5_131756417_131756718 | 0.23 |
AC116366.5 |
|
5579 |
0.14 |
chr14_24784022_24784248 | 0.23 |
LTB4R |
leukotriene B4 receptor |
229 |
0.8 |
chrX_8696930_8697081 | 0.23 |
KAL1 |
Kallmann syndrome 1 sequence |
3222 |
0.37 |
chr9_136207992_136208143 | 0.23 |
ENSG00000201451 |
. |
3406 |
0.08 |
chr7_22762779_22763152 | 0.23 |
IL6 |
interleukin 6 (interferon, beta 2) |
2538 |
0.27 |
chr11_1802236_1802476 | 0.23 |
CTSD |
cathepsin D |
17134 |
0.08 |
chr6_6885939_6886224 | 0.23 |
ENSG00000240936 |
. |
53049 |
0.17 |
chr2_106414895_106415184 | 0.23 |
NCK2 |
NCK adaptor protein 2 |
17976 |
0.25 |
chr17_7959293_7959452 | 0.23 |
ALOX15B |
arachidonate 15-lipoxygenase, type B |
16898 |
0.09 |
chr6_144480917_144481068 | 0.23 |
STX11 |
syntaxin 11 |
9329 |
0.26 |
chr10_30315881_30316032 | 0.23 |
KIAA1462 |
KIAA1462 |
32497 |
0.24 |
chr22_24938120_24938271 | 0.23 |
GUCD1 |
guanylyl cyclase domain containing 1 |
12862 |
0.12 |
chr5_177668572_177668807 | 0.23 |
PHYKPL |
5-phosphohydroxy-L-lysine phospho-lyase |
8903 |
0.2 |
chr1_161531648_161531799 | 0.23 |
RP11-5K23.5 |
|
4855 |
0.14 |
chr1_84903223_84903376 | 0.23 |
DNASE2B |
deoxyribonuclease II beta |
29386 |
0.16 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.5 | GO:0001821 | histamine secretion(GO:0001821) |
0.1 | 0.3 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.4 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.1 | 0.1 | GO:0002830 | positive regulation of type 2 immune response(GO:0002830) |
0.1 | 0.5 | GO:0001820 | serotonin secretion(GO:0001820) |
0.1 | 0.4 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.3 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 0.3 | GO:0019471 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.3 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 0.7 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 0.3 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.1 | 0.3 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.4 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.1 | 0.2 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
0.1 | 0.4 | GO:0001878 | response to yeast(GO:0001878) |
0.1 | 0.3 | GO:0002864 | regulation of acute inflammatory response to antigenic stimulus(GO:0002864) |
0.1 | 0.6 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.2 | GO:0015809 | arginine transport(GO:0015809) |
0.1 | 0.2 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.1 | 0.2 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.1 | GO:0001774 | microglial cell activation(GO:0001774) |
0.1 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.2 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.1 | 0.4 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.4 | GO:0006337 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.1 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.1 | 0.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.2 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 0.2 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.2 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.3 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.1 | 0.2 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.0 | 0.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.7 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 0.5 | GO:0043303 | mast cell activation involved in immune response(GO:0002279) mast cell degranulation(GO:0043303) |
0.0 | 0.2 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.0 | 0.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.0 | 0.4 | GO:0042119 | neutrophil activation(GO:0042119) |
0.0 | 0.1 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.0 | 0.1 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.0 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.0 | 0.4 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.0 | 0.1 | GO:0035583 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.0 | 0.2 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.1 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.0 | 0.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.1 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.0 | 0.1 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.1 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.0 | 0.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.0 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.1 | GO:0042819 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.0 | 0.2 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.0 | 0.2 | GO:0032876 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.0 | 0.6 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.0 | 0.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.0 | GO:0006168 | adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.2 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.1 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
0.0 | 0.8 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.0 | 0.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.1 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.2 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.0 | 0.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.1 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.3 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 0.1 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.0 | 0.0 | GO:0048541 | Peyer's patch development(GO:0048541) |
0.0 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.1 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) |
0.0 | 0.1 | GO:0032352 | positive regulation of hormone metabolic process(GO:0032352) positive regulation of hormone biosynthetic process(GO:0046886) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.1 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.0 | 0.1 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.2 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 0.1 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
0.0 | 0.1 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.0 | 0.6 | GO:0060334 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.2 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.0 | 0.1 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.0 | 0.0 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.0 | 0.1 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
0.0 | 0.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 0.1 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.0 | 0.1 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.0 | 0.1 | GO:0035588 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.0 | 0.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.0 | 0.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.1 | GO:0060437 | lung growth(GO:0060437) |
0.0 | 0.1 | GO:0097300 | necroptotic process(GO:0070266) programmed necrotic cell death(GO:0097300) |
0.0 | 0.1 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.0 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.0 | 0.1 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.0 | 0.0 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.0 | 0.3 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.0 | 0.1 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.0 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.1 | GO:0016265 | obsolete death(GO:0016265) |
0.0 | 0.1 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.0 | 0.1 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.1 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.0 | 0.3 | GO:0090398 | cellular senescence(GO:0090398) |
0.0 | 0.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.0 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.0 | 0.0 | GO:0060058 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.0 | 0.1 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.0 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.0 | 0.2 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.0 | 0.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.2 | GO:0032731 | positive regulation of interleukin-1 beta production(GO:0032731) |
0.0 | 0.1 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.0 | 0.1 | GO:0003181 | atrioventricular valve development(GO:0003171) atrioventricular valve morphogenesis(GO:0003181) |
0.0 | 0.1 | GO:0072600 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.0 | 0.2 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.0 | 0.1 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.0 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.0 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.0 | 0.3 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.1 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.1 | GO:0009158 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.0 | 0.0 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.0 | 0.0 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.0 | GO:0032760 | positive regulation of tumor necrosis factor production(GO:0032760) |
0.0 | 0.0 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.0 | 0.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 0.1 | GO:0060406 | regulation of penile erection(GO:0060405) positive regulation of penile erection(GO:0060406) |
0.0 | 0.1 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
0.0 | 0.0 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.0 | 0.1 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.0 | 0.1 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.0 | 0.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.1 | GO:0031033 | myosin filament organization(GO:0031033) |
0.0 | 0.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.0 | 0.1 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.0 | 0.0 | GO:0051136 | NK T cell differentiation(GO:0001865) tolerance induction to self antigen(GO:0002513) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.0 | 0.1 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.0 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.0 | GO:1901985 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.0 | 0.1 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.0 | 0.1 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.0 | 0.1 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.0 | 0.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.1 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.0 | 0.1 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.0 | 0.1 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.0 | 0.2 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.0 | 0.0 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.0 | 0.1 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.0 | 0.1 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.1 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) adaptation of signaling pathway(GO:0023058) |
0.0 | 0.2 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.0 | 0.1 | GO:0046325 | negative regulation of glucose transport(GO:0010829) negative regulation of glucose import(GO:0046325) |
0.0 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.0 | GO:0010447 | response to acidic pH(GO:0010447) |
0.0 | 0.2 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.1 | GO:0030656 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) regulation of vitamin metabolic process(GO:0030656) vitamin D biosynthetic process(GO:0042368) negative regulation of vitamin metabolic process(GO:0046137) regulation of vitamin D biosynthetic process(GO:0060556) regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
0.0 | 0.1 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.1 | GO:0019985 | translesion synthesis(GO:0019985) |
0.0 | 0.0 | GO:0003078 | obsolete regulation of natriuresis(GO:0003078) |
0.0 | 0.5 | GO:0030183 | B cell differentiation(GO:0030183) |
0.0 | 0.0 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.0 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.0 | 0.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.0 | 0.3 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.0 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.0 | 0.1 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 0.0 | GO:0070933 | histone H3 deacetylation(GO:0070932) histone H4 deacetylation(GO:0070933) |
0.0 | 0.0 | GO:0036315 | cellular response to sterol(GO:0036315) cellular response to cholesterol(GO:0071397) |
0.0 | 0.2 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.0 | 0.1 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.3 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.0 | 0.0 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.0 | 0.1 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.0 | 0.1 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.0 | 0.1 | GO:0002098 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.0 | 0.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.6 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.0 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.0 | 0.2 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.0 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.1 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.0 | 0.0 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.1 | GO:0042116 | macrophage activation(GO:0042116) |
0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.1 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.0 | 0.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.1 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 0.0 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.0 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.0 | 0.0 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.0 | 0.2 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.0 | 0.0 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.0 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.0 | 0.1 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.1 | GO:0097306 | cellular response to alcohol(GO:0097306) |
0.0 | 0.0 | GO:1903299 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.1 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.0 | 0.2 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.0 | 0.1 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.0 | 0.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.0 | GO:0055064 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.0 | 0.0 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.0 | 0.1 | GO:0000239 | pachytene(GO:0000239) |
0.0 | 0.0 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.0 | 0.0 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.0 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.0 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.0 | 0.0 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.0 | 0.0 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.1 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.0 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.1 | GO:0032675 | regulation of interleukin-6 production(GO:0032675) |
0.0 | 0.0 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.1 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.0 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.0 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.0 | 0.0 | GO:0015669 | gas transport(GO:0015669) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.1 | GO:1901070 | guanosine-containing compound biosynthetic process(GO:1901070) |
0.0 | 0.0 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.2 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 0.2 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.0 | 0.2 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.0 | 0.2 | GO:0035338 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.0 | 0.1 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.0 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.0 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.0 | 0.0 | GO:0070723 | response to sterol(GO:0036314) response to cholesterol(GO:0070723) |
0.0 | 0.0 | GO:0022605 | oogenesis stage(GO:0022605) |
0.0 | 0.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.1 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.0 | 0.0 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.2 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.0 | GO:1903313 | regulation of mRNA 3'-end processing(GO:0031440) positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.0 | 0.1 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.0 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.0 | 0.0 | GO:0010716 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.0 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.0 | 0.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.0 | GO:0052031 | modulation by symbiont of host defense response(GO:0052031) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) |
0.0 | 0.1 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.0 | 0.0 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.0 | 0.0 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.1 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.1 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.1 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.0 | 0.0 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.0 | 0.0 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.0 | 0.0 | GO:0032898 | neurotrophin production(GO:0032898) |
0.0 | 0.1 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi vesicle budding(GO:0048194) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.0 | 0.0 | GO:0046348 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.1 | GO:0051882 | mitochondrial depolarization(GO:0051882) |
0.0 | 0.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.0 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.0 | 0.0 | GO:0048569 | post-embryonic organ development(GO:0048569) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.3 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.1 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.2 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.2 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.0 | 0.2 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 0.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.0 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.3 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.0 | 0.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.1 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.2 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.4 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.2 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.1 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 0.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.1 | GO:1903561 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.0 | 0.3 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.1 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.0 | 0.4 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.0 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.4 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.1 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.0 | 0.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.1 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.0 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.0 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.0 | 0.1 | GO:0017059 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.4 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.0 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.0 | 0.1 | GO:0001740 | Barr body(GO:0001740) |
0.0 | 0.8 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.0 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.1 | GO:0016580 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.0 | 0.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.0 | 0.0 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 0.7 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 0.0 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.0 | 0.0 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.0 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.5 | GO:0031983 | vesicle lumen(GO:0031983) |
0.0 | 0.1 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.0 | 0.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.5 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.1 | 0.6 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.3 | GO:0019958 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.1 | 0.4 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.4 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.1 | 0.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 0.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.2 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 0.7 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.5 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.3 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.2 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.2 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.5 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.1 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.3 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.1 | 0.2 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.2 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 0.4 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.5 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.1 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.0 | 0.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.2 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.3 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.2 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.1 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.0 | 0.1 | GO:0052659 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.0 | 0.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.2 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.3 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.0 | 0.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.0 | 0.2 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.0 | 0.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.2 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.0 | 0.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.2 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.3 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.2 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 1.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.1 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.0 | 0.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.1 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.0 | 0.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.1 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.0 | 0.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.1 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.1 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
0.0 | 0.1 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.0 | 0.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.2 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.1 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.0 | 0.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.2 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.2 | GO:0034739 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.0 | 0.1 | GO:0004340 | glucokinase activity(GO:0004340) |
0.0 | 0.1 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.3 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.3 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.1 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.0 | 0.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.0 | 0.4 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.0 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.0 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.0 | 0.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.0 | 0.0 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.0 | 0.1 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.0 | 0.0 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.0 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.0 | 0.0 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.1 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.4 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.3 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.0 | 0.1 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.1 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.0 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.0 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.0 | 0.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.1 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.0 | 0.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.0 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.3 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.0 | 0.0 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 0.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.0 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.0 | 0.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.1 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.0 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.0 | 0.0 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.0 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.1 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.0 | 0.0 | GO:0051425 | PTB domain binding(GO:0051425) |
0.0 | 0.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.1 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.0 | 0.0 | GO:0045569 | TRAIL binding(GO:0045569) |
0.0 | 0.0 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.0 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.0 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.2 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.3 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.0 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.0 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.0 | 0.0 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.0 | 0.0 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.0 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 0.0 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.0 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.0 | 0.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.0 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.0 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.1 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.0 | 0.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 0.1 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.0 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.0 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.0 | 0.2 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.0 | 0.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 1.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.6 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.8 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 1.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 1.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.0 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.3 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.6 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 0.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 1.0 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 1.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.2 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.0 | 0.0 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.0 | 0.0 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.0 | 0.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.3 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.4 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.1 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.1 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.0 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.0 | 0.1 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.0 | 0.1 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.1 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.2 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.0 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.0 | 0.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.0 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |